Impact of Family Psychoeducation on Psychosis

July 28, 2010 updated by: Makerere University

The Role of Psychoeducation on Perceived Social Support of Postpartum Others With a Psychotic Illness

There is currently no clear involvement of families/caregivers in the care for postpartum mothers that develop postpartum psychosis. The lack of knowledge on causes of postpartum psychosis may influence the nature of perceived social support that mothers receive from caregivers. It is hoped that the provision of a culturally adapted version of family psychoeducation will bridge the knowledge gap and provide the much needed information. We therefore hypothesized that the involvement of a family member of a postpartum mother with a psychotic illness in a weekly session of family psychoeducation.

Study Overview

Detailed Description

Postpartum psychosis causes distress to the mother, baby, spouse and other primary caregivers. This is especially true for Uganda where cultural beliefs for the causation of the illness place blame on supposedly the postpartum mother's promiscuity during pregnancy (COX, 1979). Cultural perceptions on the causes of postpartum psychosis may affect the nature of social support the mothers perceive from their families when they develop the illness. Other perceptions regarding postpartum psychosis in Uganda lay blame on supernatural causes like witchcraft.

Family psychoeducation which sets out to inform families of the nature of the illness is called for so as to demystify the illness.

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kampala, Uganda, 7072
        • Recruiting
        • Makerere University College of Health Sciences
        • Contact:
        • Contact:
        • Principal Investigator:
          • Janet Nakigudde
      • Kampala, Uganda, P.O.Box 7072
        • Recruiting
        • Makerere University College of Health Sciences
        • Contact:
        • Principal Investigator:
          • Janet Nakigudde
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 50 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Postpartum mothers with a psychiatric illness in the current postpartum period.
  • Must have been admitted to the mental health facility for the current episode.

Exclusion Criteria:

  • Mothers residing out of a radius of 50 km away from the health facility.
  • Mothers that do not have caregivers.
  • Mothers who are not fluent in the language in which the study will be conducted.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Encouragement on drug compliance
The intervention for the placebo comparator will be encouragement on drug compliance
Mothers and their caregivers will be encouraged to comply with the given medication
Other Names:
  • Psychosocial intervention
Mothers and their caregivers in the placebo comparator will receive an intervention of drug compliance encouragement
Other Names:
  • Psychosocial intervention
Experimental: Family psychoeducation
The experimental group will receive weekly sessions of psychoeducation for 12 weeks in addition to receiving drug compliance encouragement
The experimental group will receive family psychoeducation for 12 sessions
Other Names:
  • Psychosocial intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
perceived social support of mothers
Time Frame: 3 months
12 weekly sessions of family psychoeducation for a period of 3 months will improve perceived social support of mothers in the intervention arm.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improvement of psychological distress of the caregivers
Time Frame: 3 months
12 weekly sessions of family psychoeducation with caregivers for a period of 3 months will improve psychological distress in caregivers of mothers that will have received family psychoeducation
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Eija Airaksinen, Karolinska Institutet

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2008

Primary Completion (Anticipated)

September 1, 2010

Study Completion (Anticipated)

October 1, 2010

Study Registration Dates

First Submitted

July 28, 2010

First Submitted That Met QC Criteria

July 28, 2010

First Posted (Estimate)

July 29, 2010

Study Record Updates

Last Update Posted (Estimate)

July 29, 2010

Last Update Submitted That Met QC Criteria

July 28, 2010

Last Verified

July 1, 2010

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postpartum Psychosis

Clinical Trials on drug compliance

Subscribe